Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Centessa Pharmaceuticals (CNTA) Net Margin (2025)

Centessa Pharmaceuticals has reported Net Margin over the past 1 years, most recently at 174.23% for Q1 2025.

  • Quarterly Net Margin changed N/A to 174.23% in Q1 2025 from the year-ago period, while the trailing twelve-month figure was 1316.88% through Dec 2025, changed N/A year-over-year, with the annual reading at 1316.88% for FY2025, N/A changed from the prior year.
  • Net Margin was 174.23% for Q1 2025 at Centessa Pharmaceuticals.
  • Over five years, Net Margin peaked at 174.23% in Q1 2025 and troughed at 174.23% in Q1 2025.